Diabetes with partial lipodystrophy following sclerodermatous chronic graft vs. host disease

Diabetic Medicine : a Journal of the British Diabetic Association
D P Rooney, M F Ryan

Abstract

The importance of adipose tissue in metabolism, as a target for insulin action and a secretor of metabolic regulatory proteins, is increasingly recognized. Lipodystrophic conditions are often associated with significant insulin resistance. The commonest acquired form occurs with highly active antiretroviral therapy (HAART) for human immunodeficiency virus infection. Other medical conditions and drugs also have the potential to cause chronic subcutaneous fat damage. We describe an unfamiliar partial lipodystrophy in a young woman, associated with markedly insulin-resistant diabetes, acquired following allogeneic bone marrow transplantation for childhood leukaemia complicated by late sclerodermatous chronic graft vs. host disease (GVHD). Clinical examination revealed scarring and lipodystrophy affecting mainly legs, thighs, buttocks and forearms but sparing her face, neck and thorax. Her serum adiponectin level was markedly reduced. However, although thiazolidinediones lower insulin resistance and increase subcutaneous peripheral fat in Type 2 diabetes, pioglitazone treatment had little effect on either serum adiponectin, glycaemic control or the lipoatrophy. In this case, effective glycaemic control was best achieved using a com...Continue Reading

References

Jan 1, 1992·Journal of the American Academy of Dermatology·O ChosidowJ Revuz
Feb 2, 2000·Nature Genetics·S ShackletonR C Trembath
Nov 5, 2002·The Journal of Clinical Endocrinology and Metabolism·Dali ChenAbhimanyu Garg
Sep 27, 2003·Diabetic Medicine : a Journal of the British Diabetic Association·Katharine R OwenAndrew T Hattersley
Mar 19, 2004·The New England Journal of Medicine·Abhimanyu Garg
May 15, 2004·British Journal of Haematology·Meghan A Higman, Georgia B Vogelsang

❮ Previous
Next ❯

Citations

Jan 1, 2010·Clinical, Cosmetic and Investigational Dermatology·Seyed Reza Mousavi
Dec 17, 2014·Orphanet Journal of Rare Diseases·Marie-Christine VantyghemUNKNOWN Société Française de Thérapie Cellulaire
Sep 3, 2010·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Alissa R SegalJeffrey A Jackson
Nov 29, 2012·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Sarah E MaysonMichael R Rickels
May 6, 2020·Expert Review of Endocrinology & Metabolism·Maria C Foss-FreitasElif A Oral
May 11, 2020·Journal of Cancer Survivorship : Research and Practice·Ava LorencUNKNOWN CTYA HSCT Adipose and Muscle Late Effects Working Group
Feb 13, 2009·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Wendy S LaneJay S Skyler
May 2, 2017·Clinical Pediatric Endocrinology : Case Reports and Clinical Investigations : Official Journal of the Japanese Society for Pediatric Endocrinology·Masanori AdachiHiroaki Goto
Aug 14, 2020·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Andrea Z PereiraMary E Flowers
Jun 21, 2017·Materials Science & Engineering. C, Materials for Biological Applications·Jay GilbertOwen G Jones
May 1, 2021·Journal of Clinical Medicine·Daniel TewsMartin Wabitsch
Oct 18, 2007·Current Opinion in Endocrinology, Diabetes, and Obesity

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.